Last update 25 Aug 2025

Human Bone Marrow Mesenchymal Stem Cells (Jiuzhitang Maker)

Overview

Basic Info

Drug Type
Stem cell therapy
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
Immune System DiseasesRespiratory DiseasesOther Diseases
Active Indication
Pulmonary Alveolar Proteinosis, AcquiredAutism Spectrum Disorder
Inactive Indication-
Originator Organization
Jiuzhitang Maker(Beijing)Cell Technology Co., Ltd.Jiuzhitang Maker(Beijing)Cell Technology Co., Ltd.
Active Organization
Jiuzhitang Maker(Beijing)Cell Technology Co., Ltd.Jiuzhitang Maker(Beijing)Cell Technology Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Human Bone Marrow Mesenchymal Stem Cells (Jiuzhitang Maker)
NCT06111846
/ Active, not recruitingPhase 2
An Open-label Phase IIa Study to Evaluate the Safety and Preliminary Efficacy of HBMMSC Injection in the Treatment of APAP
CTR20253124
/ Not yet recruitingPhase 1
评估人骨髓间充质干细胞（hBMMSC）注射液治疗孤独症谱系障碍（ASD）安全性和初步疗效的探索性研究
[Translation] An exploratory study to evaluate the safety and preliminary efficacy of human bone marrow mesenchymal stem cell (hBMMSC) injection in the treatment of autism spectrum disorder (ASD)
100 Clinical Results associated with Human Bone Marrow Mesenchymal Stem Cells (Jiuzhitang Maker)
Login to view more data
100 Translational Medicine associated with Human Bone Marrow Mesenchymal Stem Cells (Jiuzhitang Maker)
Login to view more data
100 Patents (Medical) associated with Human Bone Marrow Mesenchymal Stem Cells (Jiuzhitang Maker)
Login to view more data
100 Deals associated with Human Bone Marrow Mesenchymal Stem Cells (Jiuzhitang Maker)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pulmonary Alveolar Proteinosis, AcquiredPhase 2
China
Jiuzhitang Maker(Beijing)Cell Technology Co., Ltd.Jiuzhitang Maker(Beijing)Cell Technology Co., Ltd.
16 Oct 2023
Autism Spectrum DisorderPhase 1
China
Jiuzhitang Maker(Beijing)Cell Technology Co., Ltd.Jiuzhitang Maker(Beijing)Cell Technology Co., Ltd.
22 Aug 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free